◎ Green Cross in the vaccine market
Green Cross is a R&D-oriented company that leads the Korean biotechnology industry since its foundation in 1967. Starting from the nation's first production and sales of Plasma Fractions in 1970, which required sophisticated technology, Green Cross has striven to develop ethical drugs that are hard to produce but essential to patients. Subsequently, it i
I. Introduction of Hanmi
Hanmi is pharmaceutical company spearheading innovation in life science. Hanmi was established by Lim,Sung Gi in 1973 based on mottoes –“Human Respect” & “Creation of Value”, Hanmi has endless exerted all its power for precious human life. For the purpose of the progress of pharmaceutical industry and the supply of highly qualified medicines with the most
Hanmi co.
1973 & Founded Hanmi Pharmaceutical Co.,Ltd
1979 & Started to manufacture soft gelatine capsule on the contract
1986 &Founded the Central Research Institute
1994 & Developed a new formulation of Cyclosporin A in the form of soft gelatine capsule with Microemulsion technology
1998 & Developed Meddy, an transgenic Korean traditional Black goat
1999 & Developed G-CSF with transge
BIOTECHNOLOGY), DAIRY FARMS
HEALTHCARE
The world around us is ever-changing. Viruses, germs and process inefficiencies all conspire to affect your business. Ecolab is focused on improving the world by making it cleaner, safer and healthier. We are committed to providing our customers with innovative solutions that solve their business challenges. Everywhere safety matters. Everywhere hygiene
biotechnology company, to develop and commercialize Cialis for the treatment of erectile dysfunction.
From 1995 to 1999, Merck introduced a total of 15 new drugs, including Crixivan, a protease inhibitor used in the treatment of HIV; Fosamax, used to treat osteoporosis; and hypertension medication Cozaar. The eight drugs accounted for more than $1 billion in sales in 1996, about ten perce